Background: T cell lymphoblastic leukemia/lymphoma with the initial symptom of effusion is an uncommon condition. It may present a diagnostic challenge as lymphoblastic cells mimic normal lymphocytes under a low-power microscopic view. Cases: Two cases are presented, both male, with the first aged 31 years and the second aged 54 years. Both initially presented with chest pain and shortness of breath, and CT scans found an anterior mediastinal mass and left pleural effusion in both subjects. Cytological smears of pleural fluid in each case showed monotonous small-to-medium-sized lymphoid cells with moderate chromatin condensation and round-to-convoluted nuclei. There were prominent apoptotic bodies and mitosis in both cases. Immunohistochemistry of cell blocks demonstrated their T cell lineage and lymphoblastic nature. Diagnosis of T cell lymphoblastic leukemia/lymphoma was determined by a 3-step algorithmic approach using complete panels of immunohistochemical markers (CD3, CD20, Ki-67, CD10, CD5, CD99, CD1a, CD34, CD4, CD8, TDT, CD7, CD2 and CD68). Conclusion: An algorithmic approach based on cytological morphology and immunophenotyping is an effective way to diagnose T cell lymphoblastic leukemia/lymphoma in patients with an initial symptom of pleural effusion and insidious cytological morphology.

Keywords:
T lymphoblastic leukemia/lymphoma, Pleural effusion, Thymoma
1.
Attanoos RL, Griffin A, Gibbs AR: The use of immunohistochemistry in distinguishing reactive from neoplastic mesothelium: a novel use for desmin and comparative evaluation with epithelial membrane antigen, p53, platelet-derived growth factor-receptor, p-glycoprotein and bcl-2. Histopathology 2003;43:231-238.
2.
Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds): WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. Lyon, IARC, 2008.
3.
Ioachim HL, Medeiros LJ: Ioachim's Lymph Node Pathology, ed 4. Philadelphia, Lippincott Williams & Wilkins, 2009.
4.
Abbas AK: Cellular and Molecular Immunology, ed 5. Philadelphia, Saunders, 2003.
5.
Rozenberg G: Microscopic Haematology: A Practical Guide for the Laboratory. Chatswood, Elsevier, 2011.
6.
Cibas ES, Ducatman BS: Cytology: Diagnostic Principles and Clinical Correlates, ed 3. Philadelphia, Saunders, 2009.
7.
Shepherd SF, A'Hern RP, Pinkerton CR: Childhood T-cell lymphoblastic lymphoma - does early resolution of mediastinal mass predict for final outcome? The United Kingdom Children's Cancer Study Group (UKCCSG). Br J Cancer 1995;72:752-756.
8.
AbdullGaffar B, AlAbsi N: Lymphoblastic lymphoma with unusual cytological features in pericardial effusion fluid. Cytopathology 2012;23:65-67.
9.
Basu D, Siddaraju N, Murugan P, Badhe BA, Akkarappatty C, Dutta TK: Cytologic aspects of T-cell acute lymphoblastic leukemia presenting as a massive pericardial effusion: a case report. Acta Cytol 2009;53:337-340.
10.
Chaves FP, Quillen K, Xu D: Pericardial effusion: a rare presentation of adult T-cell leukemia/lymphoma. Am J Hematol 2004;77:381-383.
11.
Dewar AE, Krajewski AS, Murray J: T-cell lymphoma in children and young adults: clinical, immunological and pathological features. Br J Cancer 1980;42:659-667.
12.
Rosai J, Ackerman LV: Rosai and Ackerman's Surgical Pathology, ed 9. Edinburgh, Mosby, 2011.
13.
Chilosi M, Iannucci A, Menestrina F, et al: Immunohistochemical evidence of active thymocyte proliferation in thymoma: its possible role in the pathogenesis of autoimmune diseases. Am J Pathol 1987;128:464-470.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.